Clinical Trial Update: A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients [Phase 1]

View source ↗

Summary

A Phase 1 multiple-dose study of gantenerumab in Japanese patients with Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Gantenerumab (gantenerumab)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED